Global Forum

Confirmed Speakers and Session Chairs

  • Dr Ambrose Agweyu, KEMRI/Wellcome Trust Research Programme, Nairobi
  • Dr Awa Aidara-Kane, World Health Organization, Geneva
  • Dr Alex Aiken, Clinical Research Fellow, London School of Hygiene and Tropical Medicine
  • Diana Andrade, ReAct Latin America
  • Rashmi Asif, Director, Clinical Services and Training, Jhpiego, India
  • Dr Shally Awasthi,Chhatrapati Shahuji Maharaj Medical University, Lucknow
  • Honorable Dr Ghulam Nabi Azad, Minister of Health and Family Welfare of the Government of India
  • Dr Abhay Bang, founder-director, SEARCH, Maharashtra
  • Dr Rajesh Bhatia, Regional Adviser, WHO Regional Office for South East Asia
  • Nikolay Braykov, Research Analyst, Center for Disease Dynamics, Economics & Policy
  • Klever Calle, Communication Coordinator, ReAct - Action on Antibiotic Resistance
  • Hung Thai Cao, Vice Director of Medical Service Administration, Ministry of Health, Vietnam
  • Dr Johan Carlson, Director General, Swedish Institute for Communicable Disease Control
  • Dr Otto Cars, Medical faculty, Uppsala University
  • Prof Ranjit Roy Chaudhury, former Dean and Director, Postgraduate Institute of Medical Education and Research, Chandigarh
  • Dr L.S. Chauhan, National Center for Disease Control, India
  • Dr Alex Dodoo, University of Ghana Medical School and WHO Collaborating Centre for Advocacy and Training in Pharmacovigilance, Ghana
  • Prof Adriano Duse, School of Pathology of the National Health Laboratory Service and the University of the Witwatersrand, Johannesburg
  • Dr Sabiha Essack, Professor in Pharmacy, University of KwaZulu-Natal, South Africa
  • Prof N.K. Ganguly, National Institute of Immunology, New Delhi, Chair of GARP India NWG
  • Dr Ian M. Gould, Consultant Clinical Microbiologist and Director of Medical Microbiology, Aberdeen Royal Infirmary
  • Dr Hajo Grundmann, Chair for Infectious Diseases Epidemiology, University of Groningen
  • Dr Ankur Gupta, Merck Sharp and Dohme, India
  • Dr Usha Gupta, Fortis Hospital, Uttar Pradesh 
  • Martha Gyansa-Lutterodt, Director of Pharmaceutical Services and Chief Pharmacist, Ghana Ministry of Health
  • Dr Gabriel Levy Hara, Head of the Infectious Diseases Unit, Hospital Carlos G Durand, Buenos Aires
  • Marijke M Henton, Idexx Laboratories, Johannesburg
  • Dr David L. Heymann, Health Protection Agency, London
  • Dr Nguyen Quynh Hoa, Head of the Department of Pharmacy, Vietnam Cuba Friendship Hospital, Hanoi
  • Dr Mikael Hoffmann, CEO, NEPI foundation, Sweden
  • Dr Kathleen Anne Holloway, Regional Advisor in Essential Drugs and Other Medicines, WHO SEARO,
  • Dr Juan Carlos Hormazábal, Chief of Infectious Diseases, Instituto Nacional de Salud Pública, Chile
  • Dr Patrick Irungu, University of Nairobi
  • Dr Tomoko Ishibashi, Senior Deputy Regional Representative for Asia and the Pacific, World Organisation for Animal Health (OIE)
  • Dr Dean Jamison, University of Washington, Seattle
  • Dr Mohan P. Joshi, AMR Senior Technical Manager, Strengthening Pharmaceutical Systems (SPS) Program, MSH, USA
  • Dr Gareth S. Kantor, Senior Clinical Consultant, Discovery Health, South Africa
  • Dr Vishwa Mohan Katoch, Director General, Indian Council of Medical Research
  • Dr Niyada Kiatying-Angsulee, Director, Social Research Institute, and Manager, Drug System Monitor and Development Program, Faculty of Pharmaceutical Sciences, Chulalongkorn University, Bangkok
  • Dr Nguyen Van Kinh, National Institute of Infectious and Tropical Diseases (NIITD), Hanoi, Chair of GARP Vietnam NWG
  • Prof Keith P. Klugman, Emory University, Atlanta
  • Dr Anita Kotwani, Associate Professor, Department of Pharmacology, V. P. Chest Institute, University of Delhi
  • Donna Kusemererwa, Executive Director, Ecumenical Pharmaceutical Network (EPN)
  • Prof Paul Lalvani, Dean & Director, Empower School of Health, India
  • Dr Gaurav Laroia, Merck Sharp and Dohme, India
  • Dr Ramanan Laxminarayan, Center for Disease Dynamics, Economics and Policy (CDDEP), Washington DC and Public Health Foundation of India (PHFI), New Delhi.
  • Prof Cecilia Stålsby Lundborg, deputy head, Division of Global Health (IHCAR), Karolinska Institutet, Stockholm
  • Dumisile Venessa Maseko, National Health Laboratory Service, South Africa
  • Elizabeth Mathai, WHO patient safety programme, India
  • Hon. Robert Joseph Mettle-Nunoo, Deputy Minister of Health, Ghana
  • Dr Mary Murray, Global Network Coordinator, ReAct – Action on Antibiotic Resistance
  • Do Thi Thuy Nga, Oxford University Clinical Research Unit (OUCRU) in Hanoi
  • Hon. Prof Peter Anyang' Nyong'o, Minister for Medical Services, the Republic of Kenya
  • Dr Thomas O'Brien, Medical Director of the Microbiology Laboratory, Brigham and Women’s Hospital, Boston
  • Dr Iruka N Okeke, Associate Professor of Molecular Microbiology, Haverford College
  • Dr Elizabeth Ominde-Ogaja, Deputy Chief Pharmacist, Ministry of Medical Services, Kenya
  • Jayesh M. Pandit, Head, Division of Medicines Information and Pharmacovigilance, Pharmacy and Poisons Board (PPB), Kenya
  • Dr Arturo Quizhpe Peralta, Professor of Paediatrics and Dean of the Faculty of Medical Sciences, University of Cuenca, Ecuador
  • Dr Samlee Plianbangchang, Regional Director, WHO’s South-East Asia Region
  • Tambudzai Rashidi, Msc, Country Director and Chief of Party, Maternal and Child Health Integrated Program (MCHIP), Malawi
  • Prof K. Srinath Reddy, President, Public Health Foundation of India
  • Prof Gunturu Revathi, Aga Khan University Hospital, Nairobi
  • Prafull Sheth, Vice-President, International Pharmaceutical Federation (FIP)
  • Dr Nandini Shetty, Consultant Microbiologist and HPA Training Coordinator,
UCLH NHS Foundation Trust & Health Protection Agency, London
  • Prof Eric A. F. Simoes, University of Colorado Health Sciences Center, Denver
  • Dr Surinder Singh, Drugs Controller General of India
  • Satya Sivaraman, Communication Advisor, ReAct - Action on Antibiotic Resistance 
  • Dr Jeffrey M. Smith, Director for Maternal Health, Maternal and Child Health Integrated Program (MCHIP), Washington DC
  • Dr Anthony So, Sanford School of Public Policy, Duke University
  • Dr Suniti Solomon, Founder Director, Y. R. Gaitonde Center for AIDS Research and Education (YRG CARE), Chennai
  • Dr Walter Straus, Global Director for Scientific Affairs for Vaccines, Merck, USA
  • Prof Fatima Suleman, Head of School and Associate Professor, School of Pharmacy and Pharmacology, University of KwaZulu-Natal, South Africa
  • Dr Nithima Sumpradit, Bureau of Drug Control of the Food and Drug Administration and International Health Policy Program, Ministry of Public Health, Thailand
  • Dr Kurien Thomas, Head, Department of Medicine, Christian Medical College (CMC) Vellore
  • Andrea Titus, Communications Manager, Center for Disease Dynamics, Economics & Policy
  • Richard Valimba, Program Associate, Centre for Pharmaceutical Management, Management Sciences for Health, Tanzania
  • Dr Erika Vlieghe, Institute of Tropical Medicine, Antwerp
  • Dr Chand Wattal, Hony, Senior Consultant & Chairman, Dept. of Clinical Microbiology, Sir Ganga Ram Hospital, Rajinder Nagar, New Delhi
  • Dr Heiman Wertheim, clinical microbiologist and director, Oxford University Clinical Research Unit (OUCRU), Hanoi
  • Dr Andrew Whitelaw, National Health Laboratory Service (NHLS), Groote Schuur Hospital, South Africa
  • Dr Anita K. M. Zaidi Professor and Chair of Pediatrics and Child Health, Aga Khan University, Karachi, Pakistan
  • Dr Zainul Fadziruddin Zainuddin, Director, Innovations Office, Universiti Sains Malaysia

 

Speakers

Follow Us: